Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial.
BACKGROUND: Meta-analyses suggest that reboxetine may be less effective than other antidepressants. Such comparisons may be biased by lower adherence to reboxetine and subsequent handling of missing outcome data. This study illustrates how to adjust for differential non-adherence and hence derive an...
Main Authors: | Wiles, N, Fischer, K, Cowen, P, Nutt, D, Peters, T, Lewis, G, White, I |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2014
|
Similar Items
-
Severity of depression and response to antidepressants: GENPOD randomised controlled trial.
by: Wiles, N, et al.
Published: (2012) -
Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial
by: Bould, H, et al.
Published: (2012) -
Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial.
by: Bould, H, et al.
Published: (2012) -
GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocol.
by: Thomas, L, et al.
Published: (2008) -
GENetic and clinical Predictors Of treatment response in Depression: the GenPod randomised trial protocol
by: O'Donovan Michael, et al.
Published: (2008-05-01)